RxDoctor Payments Data

Mirnalis Martinez Vega, DO

Family Medicine · Decatur, GANPI 1043501000

Payments from drug & device makers

$743in general payments, 2019–2025

Across 37 payments — averaging $20.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$115
  • AstraZeneca$112
  • AbbVie$88
  • Merck$70
  • Seqirus USA Inc$64
  • Pfizer$64
  • plus $230 from 11 others

What the payments were for

  • Food & beverage$743100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$743 in reported general payments places this provider in the 55th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$78,903
Medicare patients
269
Services billed
2,070

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide34$41,538
EliquisApixaban30$29,288
OzempicSemaglutide30$28,269
JardianceEmpagliflozin16$19,983
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$14,383
EntrestoSacubitril/Valsartan12$13,609
JanuviaSitagliptin Phosphate17$10,389
MyrbetriqMirabegron16$6,772
LinzessLinaclotide12$6,397
GemtesaVibegron11$6,153
Humalog Kwikpen U-200Insulin Lispro12$5,218
Lantus SolostarInsulin Glargine,hum.Rec.Anlog35$4,654
SymbicortBudesonide/Formoterol Fumarate12$4,037
Gabapentin132$2,394
Albuterol Sulfate HfaAlbuterol Sulfate57$1,781

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$14$41,53834 claims
PfizerEliquis$64$29,28830 claims
Novo NordiskOzempic$115$28,26930 claims
NovartisEntresto$22$13,60912 claims
MerckJanuvia$70$10,38917 claims
AbbVieLinzess$88$6,39712 claims
AstraZenecaSymbicort$112$4,03712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Decatur

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →